+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Bone Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

One of the most fatal and chronic disorder now a day is Cancer. It is a highly hazardous disease with an extremely high mortality rate due to its highly invasive nature and prolonged duration of disease. Bone cancer is one the types of cancer in which the tissues of bone start growing in uncontrollable manner. This growth can be benign or malignant. In most of the cases, the bone cancer is a result from other cancers.

The major and primary symptom of the bone cancer is severe and intolerable bone pain. This pain increases over the period of time. In addition to pain, symptoms like weight loss, fatigue, bone crack, fever, muscle pain, osteoporosis, and osteopenia are also identified. The diagnostic tests may preliminary include deep study of patient’s history and reasons of pain. Afterwards, the diagnosis of the bone cancer is carried out by using some imaging studies, such as, CT scan, MRI, bone scanning, and PET scanning. Biopsy test is also used for the diagnosis and confirmation of the disease.

Bone cancer market: Segmentation

The market of bone cancer is segmented on the basis of types of bone cancer, such as, primary bone cancer and secondary bone cancer. Primary bone cancer is the type of cancer that originates from rapid and uncontrollable growth of the bone and related tissues. Whereas, secondary cancer is a type of bone cancer, in which, the cancer is originated to some other site of the body and metastasize to the bone structure. The bone cancer is also classified as, osteosarcoma, Ewing’s sarcoma, chondrosarcoma, chordomas, fibrosarcoma, and admantinomas.

Bone cancer market: Types of therapies

the market is also segmented on the basis of therapies and treatments available, such as radiation therapy, chemotherapy, cryosurgery and surgical treatments. Limb amputation surgery, limb salvage surgery or limb sparing surgery are the major surgical practices used to treat bone cancer. Whereas, in radiation therapy, high energy X-rays or gamma-rays are used to destroy the tumors. Chemotherapy is a pharmacological treatment by using anti-cancer drugs either orally or parenterally. Major drugs include strontium-89 chloride, bisphosphonates, methotrexate, denosumab, doxorubicin and many others. Cryosurgery is also sometimes used to treat the bone cancer. In addition, the market is segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region is the most dominating market in the world, owing to rapidly growing incidences of bone cancers and rising focus towards R&D for bone tumor treatments. On the other hand, Asia-Pacific and RoW regions are the most promising markets in the upcoming period, owing to rise in awareness of bone cancer, its chronic impacts and its treatments.

Bone cancer market growth

Although it accounts for much less than one percent of all cancers, the market of bone cancer is expected to grow at a steady rate during the forecast period from 2016 – 2024. This growth is anticipated to be driven by various factors, such as, R&D practices running across the globe, rising awareness amongst the population for bone cancer and other bone diseases, increasing medical infrastructure and technological advancements. Owing to R&D practices, a number of drugs and formulations are under pipeline studies and are expected to enter in the market during forecast period. However, low prevalence of the disease is the major hurdle in the market growth, followed by high cost of R&D, diagnosis and treatment.

According to American Cancer Society estimates, approximately 3,300 new cases of bone cancer are expected to diagnose in 2016, out of which, around 1490 deaths are expected due to bone cancer. Hence, this very low prevalence is the major hurdle in the market growth.

The major players operating in this market include Amgen, Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company amongst others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top